Compounds > n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine
Page last updated: 2024-09-03

n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and naloxone

n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine has been researched along with naloxone in 1 studies

Compound Research Comparison

Studies
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)		Trials
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)		Recent Studies (post-2010)
(n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine)		Studies
(naloxone)		Trials
(naloxone)		Recent Studies (post-2010) (naloxone)
2501220,1341,2573,321

Protein Interaction Comparison

ProteinTaxonomyn,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine (IC50)naloxone (IC50)
Cytochrome P450 2D6Homo sapiens (human)2
Delta-type opioid receptorMus musculus (house mouse)0.043
Delta-type opioid receptorRattus norvegicus (Norway rat)0.0219
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0019
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0019
Mu-type opioid receptorHomo sapiens (human)0.0397
Delta-type opioid receptorHomo sapiens (human)0.1896
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.05
Kappa-type opioid receptorHomo sapiens (human)0.0795
Mu-type opioid receptorMus musculus (house mouse)0.0154
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0089
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.0055

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1

Other Studies

1 other study(ies) available for n,n'-bis((2-chloroethyl)nitrosocarbamoyl)cystamine and naloxone

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008